Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Diseases | 2 | 2022 | 142 | 1.170 |
Why?
|
| Nanoparticles | 4 | 2026 | 310 | 0.920 |
Why?
|
| Drug Delivery Systems | 10 | 2026 | 224 | 0.880 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 83 | 0.750 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 4 | 2018 | 24 | 0.710 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 88 | 0.640 |
Why?
|
| Ophthalmic Solutions | 2 | 2019 | 86 | 0.600 |
Why?
|
| Posterior Eye Segment | 1 | 2019 | 2 | 0.600 |
Why?
|
| Eye | 2 | 2017 | 215 | 0.540 |
Why?
|
| Inflammation | 2 | 2026 | 1489 | 0.520 |
Why?
|
| Biocompatible Materials | 3 | 2020 | 108 | 0.410 |
Why?
|
| Delayed-Action Preparations | 5 | 2026 | 123 | 0.400 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 14 | 0.390 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 59 | 0.380 |
Why?
|
| Polymers | 4 | 2020 | 103 | 0.370 |
Why?
|
| Polyglycolic Acid | 4 | 2026 | 24 | 0.360 |
Why?
|
| Lactic Acid | 4 | 2026 | 149 | 0.340 |
Why?
|
| Dexamethasone | 3 | 2017 | 250 | 0.320 |
Why?
|
| Cornea | 5 | 2017 | 569 | 0.300 |
Why?
|
| Polyvinyl Alcohol | 2 | 2020 | 12 | 0.290 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2025 | 614 | 0.270 |
Why?
|
| Tumor Microenvironment | 3 | 2026 | 713 | 0.270 |
Why?
|
| Particle Size | 6 | 2026 | 135 | 0.260 |
Why?
|
| Myelopoiesis | 1 | 2026 | 9 | 0.240 |
Why?
|
| Interleukin-1alpha | 1 | 2026 | 11 | 0.240 |
Why?
|
| Caspase 1 | 1 | 2026 | 50 | 0.240 |
Why?
|
| Sutures | 1 | 2026 | 63 | 0.230 |
Why?
|
| Animals | 14 | 2026 | 33912 | 0.230 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2026 | 105 | 0.230 |
Why?
|
| Paclitaxel | 1 | 2026 | 130 | 0.230 |
Why?
|
| Bupivacaine | 1 | 2025 | 28 | 0.220 |
Why?
|
| Neuralgia | 1 | 2025 | 48 | 0.220 |
Why?
|
| Anesthetics, Local | 1 | 2025 | 83 | 0.210 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2025 | 78 | 0.210 |
Why?
|
| Caspase 2 | 1 | 2024 | 26 | 0.210 |
Why?
|
| Neutrophils | 1 | 2026 | 371 | 0.200 |
Why?
|
| Mice | 10 | 2026 | 18301 | 0.190 |
Why?
|
| Bone Marrow | 1 | 2025 | 317 | 0.190 |
Why?
|
| Cerium | 1 | 2022 | 7 | 0.190 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1826 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2026 | 463 | 0.180 |
Why?
|
| Nanotechnology | 2 | 2015 | 50 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2025 | 1105 | 0.180 |
Why?
|
| Dry Eye Syndromes | 2 | 2016 | 296 | 0.170 |
Why?
|
| Neoplasms | 2 | 2014 | 3016 | 0.170 |
Why?
|
| Platelet Factor 4 | 1 | 2021 | 22 | 0.170 |
Why?
|
| CD8 Antigens | 1 | 2021 | 39 | 0.170 |
Why?
|
| CD4 Antigens | 1 | 2021 | 54 | 0.170 |
Why?
|
| Bioprinting | 1 | 2020 | 13 | 0.160 |
Why?
|
| Hernia, Ventral | 1 | 2020 | 35 | 0.160 |
Why?
|
| Microtechnology | 2 | 2011 | 6 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 3748 | 0.160 |
Why?
|
| Herniorrhaphy | 1 | 2020 | 71 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 521 | 0.150 |
Why?
|
| Retina | 1 | 2022 | 425 | 0.150 |
Why?
|
| Chemical Phenomena | 1 | 2019 | 46 | 0.150 |
Why?
|
| Administration, Topical | 1 | 2019 | 130 | 0.150 |
Why?
|
| Drug Liberation | 3 | 2026 | 45 | 0.140 |
Why?
|
| Rats | 2 | 2025 | 3370 | 0.140 |
Why?
|
| Surface Properties | 1 | 2019 | 81 | 0.140 |
Why?
|
| Nanomedicine | 1 | 2019 | 33 | 0.140 |
Why?
|
| Leydig Cells | 1 | 2018 | 21 | 0.140 |
Why?
|
| Polyesters | 1 | 2018 | 37 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 1211 | 0.140 |
Why?
|
| Biofilms | 1 | 2019 | 96 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2022 | 791 | 0.130 |
Why?
|
| Apoptosis | 1 | 2024 | 1827 | 0.130 |
Why?
|
| Drug Carriers | 2 | 2026 | 124 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 146 | 0.130 |
Why?
|
| Nanostructures | 3 | 2016 | 69 | 0.130 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2017 | 12 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2465 | 0.130 |
Why?
|
| Cytokines | 2 | 2020 | 1339 | 0.130 |
Why?
|
| Cysteamine | 1 | 2016 | 16 | 0.120 |
Why?
|
| Cystinosis | 1 | 2016 | 16 | 0.120 |
Why?
|
| Eye Burns | 1 | 2016 | 16 | 0.120 |
Why?
|
| Burns, Chemical | 1 | 2016 | 31 | 0.120 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2015 | 13 | 0.110 |
Why?
|
| Bacteria | 1 | 2019 | 521 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 301 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 115 | 0.090 |
Why?
|
| Hydrogels | 2 | 2010 | 92 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1545 | 0.080 |
Why?
|
| Mutation | 1 | 2024 | 6099 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 79 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2602 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 4738 | 0.060 |
Why?
|
| Humans | 9 | 2026 | 131163 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2026 | 47 | 0.060 |
Why?
|
| Pyroptosis | 1 | 2026 | 35 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2025 | 57 | 0.060 |
Why?
|
| Cell Self Renewal | 1 | 2024 | 48 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2026 | 336 | 0.050 |
Why?
|
| Female | 8 | 2026 | 70963 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2025 | 511 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 14 | 0.040 |
Why?
|
| DNA Damage | 1 | 2024 | 511 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2885 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4697 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 133 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 57 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 299 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 75 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 700 | 0.040 |
Why?
|
| Cells, Immobilized | 1 | 2018 | 8 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 95 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1011 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 163 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 197 | 0.030 |
Why?
|
| Cystine | 1 | 2016 | 14 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1928 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2018 | 152 | 0.030 |
Why?
|
| Alkalies | 1 | 2016 | 25 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 826 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 56 | 0.030 |
Why?
|
| Indazoles | 1 | 2015 | 35 | 0.030 |
Why?
|
| Corneal Neovascularization | 1 | 2015 | 13 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 357 | 0.030 |
Why?
|
| Extracellular Fluid | 1 | 2014 | 11 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 63 | 0.030 |
Why?
|
| Microfluidics | 1 | 2014 | 31 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 145 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 209 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 348 | 0.030 |
Why?
|
| Imidazoles | 1 | 2015 | 219 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 232 | 0.020 |
Why?
|
| Male | 3 | 2025 | 64957 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 674 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 523 | 0.020 |
Why?
|
| Wound Healing | 1 | 2015 | 490 | 0.020 |
Why?
|
| Silicon | 1 | 2009 | 13 | 0.020 |
Why?
|
| Gelatin | 1 | 2009 | 16 | 0.020 |
Why?
|
| Phase Transition | 1 | 2009 | 15 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 633 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 73 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 276 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 512 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1088 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 1186 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28601 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 31282 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12936 | 0.010 |
Why?
|